Jeff Yass’s PMV Pharmaceuticals PMVP Stock Holding History

Jeff Yass’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,800	Closed	-$39.7K	–	13091
2023 Q4	$39.7K	Sell	12,800 -241,400	-95%	-$639K	﹤0.01%	11800
2023 Q3	$1.56M	Buy	+254,200	New	+$1.75M	﹤0.01%	5647
2023 Q2	–	Sell	-19,200	Closed	-$91.6K	–	12893
2023 Q1	$91.6K	Sell	19,200 -10,900	-36%	-$76.7K	﹤0.01%	11360
2022 Q4	$262K	Sell	30,100 -500	-2%	-$5.33K	﹤0.01%	9434
2022 Q3	$364K	Sell	30,600 -49,700	-62%	-$718K	﹤0.01%	9316
2022 Q2	$1.14M	Sell	80,300 -87,000	-52%	-$1.27M	﹤0.01%	6198
2022 Q1	$3.48M	Buy	+167,300	New	+$2.95M	﹤0.01%	4332

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Jeff Yass's PMVP Position: Q2 2026 in Review

Jeff Yass opened a new position in PMV Pharmaceuticals (PMVP) in Q2 2026: 37,531 shares worth $50.3K. The stake represents ﹤0.01% of the portfolio and ranks #12827 among its holdings. This is a return to the name: Jeff Yass previously reported a position in PMVP as recently as Q4 2025.

Jeff Yass first reported a position in PMVP in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.63M in Q1 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

Jeff Yass held 37,531 shares of PMV Pharmaceuticals worth $50.3K as of Q2 2026.
PMV Pharmaceuticals was a new Jeff Yass position in Q2 2026.
PMV Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12827 holding.
Jeff Yass first reported a position in PMV Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
Jeff Yass's PMV Pharmaceuticals position peaked at $1.63M in Q1 2023.
64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.